Literature DB >> 15946687

Middle cerebral artery dissections: differences between isolated and extended dissections of internal carotid artery.

Chin-Hsien Lin1, Jiann-Shing Jeng, Ping-Keung Yip.   

Abstract

Isolated middle cerebral artery dissection (MCAD) has rarely been encountered clinically and few have reviewed it systemically. The etiologies, clinical manifestations, natural clinical course and prognosis of MCAD remain poorly understood. From 1995 to 2004, there were 5 cases diagnosed clinically and angiographically to have MCAD (isolated MCAD in 1, ICAD-MCAD in 4) from a medical center in Taiwan. MEDLINE (1966-2003) was searched for published articles in English that concerned the diagnosis of MCAD. Clinical presentations, stroke types, angiographic findings, etiologies, treatment strategies and outcomes were compared between cases with isolated MCAD or ICAD-MCAD. There were 23 cases (male, 46%; mean age, 22.9+/-19.5 years) with 24 events of isolated MCAD and 31 cases (male, 47%; mean age, 22.2+/-12.9 years) with 35 events of ICAD-MCAD. The types of stroke in isolated MCAD group included subarachnoid hemorrhage (12%) and cerebral infarction (88%); and in ICAD-MCAD group were subarachnoid hemorrhage (6%) and cerebral infarction (94%). The presenting symptoms were similar between both groups. Fluctuating course was more often in isolated MCAD than in ICAD-MCAD (17% vs. 3%, p=0.061). Recurrence of dissection events in both groups was infrequent (4% vs. 9%, p=0.56). Both groups had high case-fatality rates (MCAD, 48%; ICAD-MCAD, 58%). The cause of dissection in both groups was idiopathic in the majority. Congenital vessel wall defects were found in 26% of ICAD-MCAD, but in only 4% of isolated MCAD (p=0.066). In contrast, preceded trauma was more often found in isolated MCAD than ICAD-MCAD (35% vs. 19%, p=0.085). Arteritis was noted in 16% of ICAD-MCAD patients, but none in isolated MCAD. Angiography revealed segmental stenosis in 72% of isolated MCAD and 96% of ICAD-MCAD. Aneurysmal dilatation of the involved cerebral arteries was noted in 28% of isolated MCAD, but none in MCAD-ICAD. Both isolated MCAD and ICAD-MCAD can cause vascular events with high mortality rates. Several aspects differed between 2 groups, including clinical course, underlying etiologies and angiographic findings.

Entities:  

Mesh:

Year:  2005        PMID: 15946687     DOI: 10.1016/j.jns.2005.03.047

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Monotherapy with stenting in subarachnoid hemorrhage (SAH) after middle cerebral artery dissection.

Authors:  Ajit S Puri; Matthew J Gounis; Francesco Massari; Mary Howk; John Weaver; Ajay K Wakhloo
Journal:  BMJ Case Rep       Date:  2015-04-01

2.  Diagnostic usefulness of high resolution cross sectional MRI in symptomatic middle cerabral arterial dissection.

Authors:  Hai-Ong Lee; Hyo-Sung Kwak; Gyung-Ho Chung; Seung-Bae Hwang
Journal:  J Korean Neurosurg Soc       Date:  2011-06-30

3.  Symptomatic unruptured isolated middle cerebral artery dissection: clinical and magnetic resonance imaging features.

Authors:  P H Gao; L Yang; G Wang; L Guo; X Liu; B Zhao
Journal:  Clin Neuroradiol       Date:  2014-09-06       Impact factor: 3.649

4.  Isolated middle cerebral artery dissection: a systematic review.

Authors:  Ganesh Asaithambi; Pradeepan Saravanapavan; Vaibhav Rastogi; Sheema Khan; Sharatchandra Bidari; Anna Y Khanna; Latha Ganti; Adnan I Qureshi; Vishnumurthy Shushrutha Hedna
Journal:  Int J Emerg Med       Date:  2014-12-17

5.  Rapid improvement of angiostenosis due to isolated middle cerebral artery dissection: A case report.

Authors:  Li Zhang; Guangxian Nan; Ying Mao; Lumei Chi
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

6.  Superficial Temporal Artery-middle Cerebral Artery Anastomosis for Ischemic Stroke due to Dissection of the Intracranial Internal Carotid Artery with Middle Cerebral Artery Extension.

Authors:  Masashi Ikota; Gen Kusaka; Yuichi Tanaka
Journal:  NMC Case Rep J       Date:  2018-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.